ArticlePloS one2020

Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance.

Rachel A O'Keefe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.